BIRC2 and pachyonychia congenita: Taken together, these findings provide compelling evidence that CITED4 mediates GEM-resistant PC features, in part, by directly activating the expression of BIRC2, encoded by a CITED4-target gene, with known anti-apoptotic functions, both in vitro and in vivo.